CoChat

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8+ T cells. HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by CD8+ T cells. However, the relative contributions of HLA-A and -B alleles have not been evaluated. We performed a comprehensive analysis of the class I restricted CD8+ T-cell responses against human immunodeficiency virus (HIV-1), immune control of which is dependent upon virus-specific CD8+ T-cell activity. In 375 HIV-1-infected study subjects from southern Africa, a significantly greater number of CD8+ T-cell responses are HLA-B-restricted, compared to HLA-A (2.5-fold; P = 0.0033). Here we show that variation in viral set-point, in absolute CD4 count and, by inference, in rate of disease progression in the cohort, is strongly associated with particular HLA-B but not HLA-A allele expression (P < 0.0001 and P = 0.91, respectively). Moreover, substantially greater selection pressure is imposed on HIV-1 by HLA-B alleles than by HLA-A (4.4-fold, P = 0.0003). These data indicate that the principal focus of HIV-specific activity is at the HLA-B locus. Furthermore, HLA-B gene frequencies in the population are those likely to be most influenced by HIV disease, consistent with the observation that B alleles evolve more rapidly than A alleles. The dominant involvement of HLA-B in influencing HIV disease outcome is of specific relevance to the direction of HIV research and to vaccine design.

Overview

Integrity signals

Registry

Crossref · 10.1038/nature03113

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Marsh, S. G. E., Parham, P. & Barber, L. D. The HLA Facts Book (Academic, London, 2000)

Cited by

See all 842

Metadata

Authors
Kiepiela, P., Leslie, A. J., Honeyborne, I., Ramduth, D., Thobakgale, C., Chetty, S., Rathnavalu, P., Moore, C., Pfafferott, K. J., Hilton, L., Zimbwa, P., Moore, S., Allen, T., Brander, C., Addo, M. M., Altfeld, M., James, I., Mallal, S., Bunce, M., Barber, L. D., Szinger, J., Day, C., Klenerman, P., Mullins, J., Korber, B., Coovadia, H. M., Walker, B. D., & Goulder, P. J. R.
Affiliations
  • University of KwaZulu-Natal (ZA)
  • University of Oxford (GB)
  • Murdoch University (AU)
  • University of Washington (US)
  • Massachusetts General Hospital (US)
  • Anthony Nolan (GB)
  • Santa Fe Institute (US)
  • Howard Hughes Medical Institute (US)
Corresponding author
Goulder, Philip J. R.
Venue
Nature
Published
2004-12
Volume
432
Issue
7018
Pages
769-775
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2045551237
Cited by
842
References
27
Citations by year
2026: 11 · 2025: 13 · 2024: 11 · 2023: 16 · 2022: 21 · 2021: 25 · 2020: 19 · 2019: 29 · 2018: 30 · 2017: 30 · 2016: 25 · 2015: 38 · 2014: 38 · 2013: 49 · 2012: 69
FWCI
17.50
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • Murdoch University Research Portal (submittedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Keywords
HLA-B, HLA-A, HIV-1, CD8+ T cell responses, HLA class I restriction, viral set point, CD4 count, disease progression, HLA polymorphism, HIV vaccine design
MeSH terms
Africa, Southern, Biological Evolution, Female, Gene Frequency, Humans, Infant, Male, Polymorphism, Genetic, HLA-A Antigens, HLA-B Antigens, HIV-1, HIV Infections, Gene Products, nef, CD8-Positive T-Lymphocytes, Epitopes, T-Lymphocyte, Viral Load, nef Gene Products, Human Immunodeficiency Virus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.